Skip to main content

How VA Rates Prostate Conditions (DC 7527 and 7528)

Quick summary
Prostate conditions are rated under DC 7527 as voiding dysfunction or urinary tract infection, whichever is predominant, while active prostate cancer rates 100 percent under DC 7528. Here is the full voiding dysfunction scale, the six month cancer re-exam rule, and the Agent Orange presumption.
What this guide covers
  • How VA rates prostate conditions
  • The voiding dysfunction scales
  • Prostate cancer: 100 percent while active
  • The residual rating is where cancer claims go wrong
  • Agent Orange and prostate cancer
By the editorial deskUpdated Sep 18, 2026

A prostate rating is built from bathroom arithmetic. The code has no percentages of its own. It borrows the voiding scales, where the difference between 20, 40, and 60 percent is literally how many pads you change per day and how often you wake at night. The word "predominant" means the exam must document every scale, because you are owed whichever one fits highest.

How VA rates prostate conditions

Prostate gland injuries, infections, hypertrophy (BPH), postoperative residuals, and bladder outlet obstruction are all rated under diagnostic code 7527 (38 CFR 4.115b), which contains no percentages of its own. Instead it directs VA to rate the condition as voiding dysfunction or urinary tract infection, whichever is predominant, using the dysfunction scales in 38 CFR 4.115a. Prostate cancer is different: as a malignant neoplasm of the genitourinary system it rates under DC 7528.

The voiding dysfunction scales

Voiding dysfunction is rated under whichever of three sub-scales fits best:

  • Urine leakage: 20 percent when absorbent materials must be changed less than 2 times per day; 40 percent when changed 2 to 4 times per day; 60 percent when changed more than 4 times per day or an appliance is required.
  • Urinary frequency: 10 percent for a daytime voiding interval between two and three hours or awakening to void twice per night; 20 percent for an interval between one and two hours or waking three to four times per night; 40 percent for an interval under one hour or waking five or more times per night.
  • Obstructed voiding: 10 percent for marked obstructive symptoms (hesitancy, slow or weak stream) with post-void residuals over 150 cc, markedly diminished peak flow, recurrent infections, or stricture requiring periodic dilatation; 30 percent for urinary retention requiring intermittent or continuous catheterization.

Recurrent urinary tract infection rates 10 percent with long-term suppressive therapy or 1 to 2 hospitalizations per year, and 30 percent when it requires drainage, more than 2 hospitalizations per year, or continuous intensive management.

Prostate cancer: 100 percent while active

Under DC 7528, active malignancy rates 100 percent, and that 100 percent continues through treatment. Six months after any antineoplastic treatment ends, including surgery, radiation, chemotherapy, hormonal therapy, immunotherapy, or other therapy, VA schedules a mandatory examination. Any reduction after that exam must follow 38 CFR 3.105(e), which requires advance written notice and a chance to respond. If there is no recurrence or metastasis, the residuals are then rated as voiding dysfunction or renal dysfunction, whichever is predominant.

The residual rating is where cancer claims go wrong

Post-treatment prostate cancer ratings frequently drop from 100 percent to 20 or 40 percent based on the residual exam, and the difference between those numbers is pad counts and voiding intervals. Before the six month exam, keep a simple voiding diary: how many pads per day, how often you urinate, how many times you wake at night. Erectile dysfunction after prostate surgery is separately compensable through special monthly compensation (SMC-K) even at a 0 percent rating.

Agent Orange and prostate cancer

Prostate cancer is on the presumptive list for herbicide exposure (38 CFR 3.309(e)). A veteran with qualifying Vietnam-era, Korean DMZ, or other recognized herbicide exposure does not need a medical nexus opinion. The diagnosis plus qualifying service establishes service connection.

Common rating details veterans overlook

  • "Whichever is predominant" is a choice you can influence. Make sure the exam documents all three voiding scales so the highest-fitting one is used.
  • The pad count thresholds are exact (under 2, 2 to 4, more than 4 per day), so document the real number, not "several."
  • ED after prostate treatment earns SMC-K on top of the schedular rating, and it is routinely missed.
  • A reduction after the six month cancer exam is not automatic. The 3.105(e) procedures give you notice and a chance to submit evidence first.

Related on this site

For questions about your specific ratings or decision, contact your Veterans Service Officer (VSO), an accredited claims agent, or an accredited attorney. Browse the accredited representative directory or verify a representative's accreditation before sharing your records.
This is an educational estimate and not a guarantee of benefits, ratings, or back pay. VA makes all final determinations. We are not a law firm, VSO, accredited claims agent, or VA representative. We provide educational information only and encourage veterans to seek accredited help for individual claim advice. The Veteran Benefit Desk™ is a veteran founded independent digital publication and education platform that helps veterans understand VA disability claims, ratings, evidence, and appeals using clear explanations, original research, and cited public sources.
Printed from The Veteran Benefit Desk, https://veteranbenefitdesk.com/education/how-va-rates-prostate-conditions-dc-7527-7528. Figures reflect this page as published. Rates change each December; confirm current amounts at veteranbenefitdesk.com before relying on them.
We use only strictly necessary, first-party cookies. No advertising or cross-site tracking cookies run on this site. We use limited first-party, cookieless measurement to understand site performance and prevent abuse: no third-party pixels, no ad profiling, and no selling or sharing of personal information for behavioral advertising. We honor Global Privacy Control signals automatically, and if we ever add optional cookies, the choice you save here will govern them. Read our Privacy Policy.